Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 490.00
-53.00 (-9.76%)
At close: Feb 11, 2026
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 60.77 billion as of February 13, 2026. Its market cap has decreased by -25.84% in one year.
Market Cap
60.77B
Enterprise Value
77.91B
Revenue
21.10B
Ranking
n/a
PE Ratio
15.03
Stock Price
490.00
Market Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 60.77B, an increase of 1,822.02%. That is a compound annual growth rate of 29.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 60.77B | 0.41% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Lotus Pharmaceutical | 76.92B |
| Center Laboratories | 29.64B |
| TTY Biopharm Company | 20.74B |
| Grape King Bio | 18.07B |
| Alar Pharmaceuticals | 17.87B |
| ScinoPharm Taiwan | 17.12B |
| Synmosa Biopharma | 16.25B |